Honey bee health issues get increasing attention: beekeepers, policy makers and general public are concerned about the most well known pollinator. First of all, Varroa destructor is still the major threat for honeybee colonies. Though several treatments are available, this parasitic mite is often responsible for colony losses over winter. In addition, documentation for many treatments are incomplete or beekeepers observe a loss of efficacy. Therefore, there is need for developing new treatments, improving existing formulations or acquiring information about clinical and preclinical data.
Emerging pathogens (Nosema ceranae, honey bee viruses) and introduced pests (Small Hive Beetle) concern beekeepers. For these new threats only few to no treatments are available. In addition, their importance varies in different regions. For instance, while Nosema ceranae is an important, though often neglected, threat in Southern Europe, no problems occur in Central and Northern Europe. Therefore, it is important to consider the different beekeeping realities in the development of new therapies.
Services for honey bee health
BeeSafe has long-year expertise on honey bee pathology studies in several European countries (Germany, Italy, Spain, France, Austria and UK). Serving as your external R&D department, it attends the whole process from the idea over the clinical studies in the field until the registration process (expert reports and dossiers (Part IV)). Together with its partners, also residue and pharmacoresistance studies are possible.